Sign In
Buy TRCK
$0.643
-0.0072 (-1.11%)
At Close: Jul 31, 2026
Home Builder Stocks Are on Track for Worst February in 5 Years. What's Dragging Them Down.
04:54pm, Wednesday, 19'th Feb 2025
High construction costs, rising mortgage rates, and looming tariffs are pressuring the stocks.
American Water Reports 2024 Results on Track; Affirms Long-Term Growth Targets; CEO Hardwick to Retire in May, Griffith to Assume CEO Role
04:31pm, Wednesday, 19'th Feb 2025
CAMDEN, N.J.--(BUSINESS WIRE)--American Water Works Company, Inc. (NYSE: AWK) today reported earnings of $1.22 per share for the fourth quarter 2024 compared to $0.88 per share in 2023, and full year
Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors
08:04am, Wednesday, 19'th Feb 2025
Life sciences investment firm Deep Track Capital is launching a board fight at Dynavax Technologies , pressing for new directors to prioritize the development of the company's hepatitis B vaccine inst
Fast Retailing's Next Development Phase Likely To Continue An Impressive Growth Track Record
03:04am, Wednesday, 19'th Feb 2025
Fast Retailing's recent results have been mixed, with weather impacting sales in Japan and weak consumer spending hitting results in China, while other markets have been quite strong. Weather has been
SAN FRANCISCO and SUZHOU, China , Feb. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercial
Gold Price Forecast: On Track for Record High Closing Price
04:44pm, Thursday, 13'th Feb 2025
A bullish Marubozu pattern confirms strength in gold, setting up the metal for higher targets, with resistance levels aligning at $2,981, $2,982, and possibly $3,000.
S&P 500 Remains on Track for 6400-6500
03:20pm, Thursday, 13'th Feb 2025
If the bulls hold above last Monday's low at $6003 and especially the January 13 low at $5773, they remain in charge, and a rally to $6365ish is underway.
NKGen Biotech Receives U.S. FDA Fast Track Designation for Troculeucel for the Treatment of Moderate Alzheimer's Disease
08:00am, Wednesday, 12'th Feb 2025
The Fast Track designation accelerates troculeucel's path to U.S. FDA submission for the treatment of patients with moderate Alzheimer's disease. NKGen will benefit from increased FDA interactions, en
Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status
07:30am, Wednesday, 12'th Feb 2025
CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatmen
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
08:30am, Monday, 10'th Feb 2025
February 10, 2025 Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Underscores unmet need for a therapeutic alternative with the potential to delay or prevent
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif., Feb.
SAN FRANCISCO , Feb. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleuk
Track Group Reports 1st Quarter Fiscal 2025 Financial Results
11:00am, Friday, 07'th Feb 2025
NAPERVILLE, Ill., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Track Group, Inc. (OTCQB: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its fiscal quar
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Las Vegas Sands Stock Soars After Earnings. Bull Case Is Back On Track, Analyst Says.
11:20am, Thursday, 30'th Jan 2025
Fourth-quarter adjusted earnings came in at 54 cents a share on revenue of $2.9 billion.
